Richard J. Poulton - 15 Nov 2021 Form 4 Insider Report for ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. (MDRX)

Role
President & CFO
Signature
Holly O'Berry by power of attorney for Richard Poulton
Issuer symbol
MDRX
Transactions as of
15 Nov 2021
Net transactions value
-$330,802
Form type
4
Filing time
16 Nov 2021, 17:32:47 UTC
Previous filing
17 Aug 2021
Next filing
11 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDRX Common Stock Sale $163,816 -10,000 -1.7% $16.38 579,095 15 Nov 2021 Direct F1, F2
transaction MDRX Common Stock Sale $166,986 -10,000 -1.7% $16.70 569,095 16 Nov 2021 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale of shares reported in the Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021.
F2 These transactions were executed in multiple trades at prices ranging from $16.23 to $16.54. The prices reported reflect the weighted average sale price on the transaction date. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F3 These transactions were executed in multiple trades at prices ranging from $16.54 to $16.87. The prices reported reflect the weighted average sale price on the transaction date. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F4 The beneficial ownership number includes 115 shares obtained through the reporting person's involvement in the Company's Employee Stock Purchase Plan.